New Directions in Affective Disorders pp 123-125 | Cite as
Lithium Inhibition of Adenylate Cyclase Activity: Site of Action and Interaction with Divalent Cations
- 1 Citations
- 16 Downloads
Abstract
Several studies in man and experimental animals have demonstrated that acute and chronic lithium administration inhibits various stimulated adenylate cyclase activities. Thus lithium inhibits renal antidiuretic hormone (ADH)-stimulated adenylate cyclase activity and thyroid-stimulating hormone (TSH)-stimulated enzyme activity in the thyroid. Other peripheral tissues are also affected by lithium, e.g., platelet and lymphocyte adenylate cyclase. Studies on this enzyme in the central nervous system (CNS) have elucidated that lithium in vitro inhibits the adenylate cyclase in cerebral cortex, corpus striatum, neurohypophysis, hippocampus, pineal gland, and retina. It has been assumed that this inhibition of the adenylate cyclase activity, resulting in dampening of the transmission of neurotransmitter signals, may be of relevance for the mechanism of action of lithium in the treatment of manic-depressive disorders.
Keywords
Adenylate Cyclase Divalent Cation Adenylate Cyclase Activity Corpus Striatum Pharmacol ToxicolPreview
Unable to display preview. Download preview PDF.
References
- 1.Fossel ET, Sarasua MM, Koehler KA. A lithium-7 NMR investigation of the lithium ion interaction with phosphatidylcholine-phosphatidylglycerol membranes: observation of calcium and magnesium ion competition. J Magnet Reson 1985; 64: 536 – 540.Google Scholar
- 2.Cech SY, Broaddus WC, Maguire ME. Adenylate cyclase: the role of magnesium and other divalent cations. Mol Cell Biochem 1980; 33: 67 – 92.PubMedCrossRefGoogle Scholar
- 3.Ebstein RP, Hermoni M, Belmaker RH. The effect of lithium on noradrenaline-induced cyclic AMP accumulation in rat brain; inhibition after chronic treatment and absence of supersensitivity. J Pharmacol Exp Ther 1980; 213: 161 – 167.PubMedGoogle Scholar
- 4.Geisler A, Klysner R. The effect of lithium in vitro and in vivo on dopamine-sensitive adenylate cyclase activity in dopaminergic areas of the rat brain. Acta Pharmacol Toxicol (Copenh) 1985; 56: 1 – 5.CrossRefGoogle Scholar
- 5.Hotta I, Yamawaki S. Lithium decreases 5-HT1 receptors but increases 5-HT-sensitive adenylate cyclase activity in rat hippocampus. Biol Psychiatry 1986; 21: 1382 – 1390.PubMedCrossRefGoogle Scholar
- 6.Mørk A, Geisler A. Effects of lithium on calmodulin-stimulated adenylate cyclase activity in cortical membranes from rat brain. Pharmacol Toxicol 1987; 60: 17 – 23.PubMedCrossRefGoogle Scholar
- 7.Newman ME, Belmaker RH. Effects of lithium in vitro and ex vivo on components of the adenylate cyclase system in membranes from the cerebral cortex of the rat. Neuropharmacology 1987; 26: 211 – 217.PubMedCrossRefGoogle Scholar
- 8.Andersen PH, Geisler A. Lithium inhibition of forskolin-stimulated adenylate cyclase. Neuropsychobiology 1984; 12: 1 – 3.PubMedCrossRefGoogle Scholar
- 9.Mørk A, Geisler A. Mode of action of lithium on the catalytic unit of adenylate cyclase from rat brain. Pharmacol Toxicol 1987; 60: 241 – 248.PubMedCrossRefGoogle Scholar